01 2Aspen Pharmacare Holdings
02 1Cohance Lifesciences
03 4Alfred E Tiefenbacher GmbH
04 1ANGITA PHARMA INC.
05 3Actavis Inc
06 2Adcock Ingram
07 5Alembic Pharmaceuticals Limited
08 2Alphapharm PTY Ltd
09 2Anchen Pharmaceutical, Inc
10 6Apotex Inc
11 2Arrow Pharmaceuticals
12 2Ascent Innovative Medicines
13 2Aspire Lifesciences Pvt Ltd
14 2Cipla Medpro South Africa
15 2Eurofarma Laboratorios S.A
16 2Generic Health
17 3Hikma Pharmaceuticals
18 2INNOVATA PHARMACEUTICALS
19 2Intellipharmaceutics Corporation
20 2JAMP PHARMA
21 1Jivita Health Care
22 3Lupin Ltd
23 2NORVIUM BIOSCIENCE
24 1Noucor
25 2Osmotica Pharmaceuticals
26 2PRO DOC LIMITEE
27 2Pfizer Consumer Healthcare
28 7Pfizer Inc
29 2Pharma Dynamics
30 2Precise Group
31 3Rubicon Research
32 2SANIS HEALTH INC
33 6Sandoz B2B
34 2Taro Pharmaceutical Industries
35 2Teva Pharmaceutical Industries
36 5Yichang Humanwell Pharmaceutical
37 3Zydus Pharmaceuticals
38 6Blank
01 4Coated Tablet
02 3ER Tablet
03 2Extended Release Tablet
04 4Extended-Release Tablet
05 2FCT
06 2Granules
07 4Prolonged Release tablet
08 1Sustain Release Pellet
09 1Sustained Release Tablet
10 10TAB
11 19TABLET (EXTENDED-RELEASE)
12 34TABLET, EXTENDED RELEASE;ORAL
13 2Tablet
14 14Blank
01 4DISCN
02 4EU Dossier Readiness-Q1 2020
03 12Generic
04 2Originator
05 19Prescription
06 28RX
07 33Blank
01 128 Enzude 100Mg Extended Release Tablets
02 128 Enzude 50Mg Extended Release Tablets
03 1AG-DESVENLAFAXINE
04 2APO-DESVENLAFAXINE
05 2APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS
06 2APO-Desvenlafaxine MR
07 2BTC Desvenlafaxine
08 2DESVEN
09 8DESVENLAFAXINE
10 25DESVENLAFAXINE SUCCINATE
11 1Depven 100 XL
12 1Depven 50 XL
13 2Desfax
14 2Deslafeks
15 1Deslafore XR 100
16 1Deslafore XR 50
17 2Desvenlafaxine GH XR
18 2Desvenlafaxine Sandoz
19 1Exlov XR 100 mg
20 1Exlov XR 50 mg
21 1Exsira 100mg
22 1Exsira 50mg
23 2JAMP DESVENLAFAXINE
24 2KHEDEZLA
25 5PRISTIQ
26 2Pristiq
27 1Pristiq 100Mg Extended Release Tablets 28
28 1Pristiq 50Mg Extended Release Tablets 28
29 2SANDOZ DESVENLAFAXINE
30 2TARO-DESVENLAFAXINE
31 2TEVA-DESVENLAFAXINE
32 1Voloxin 100mg
33 1Voloxin 50mg
34 19Blank
01 14Australia
02 4Brazil
03 19Canada
04 2China
05 4Germany
06 8India
07 12South Africa
08 5Spain
09 34USA
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Voloxin 50mg
Dosage Form : TAB
Dosage Strength : 50mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Pellet
Dosage Strength : 41.38%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Voloxin 100mg
Dosage Form : TAB
Dosage Strength : 100mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2016-07-29
Application Number : 204065
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2016-07-29
Application Number : 204065
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2016-07-29
Application Number : 204065
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204003
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204003
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2018-09-14
Application Number : 204003
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2013-03-04
Application Number : 204150
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DESVENLAFAXINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 204009
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DESVENLAFAXINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 204009
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2016-02-16
Application Number : 204082
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2017-08-28
Application Number : 204082
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2016-02-16
Application Number : 204083
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRISTIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2008-02-29
Application Number : 21992
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRISTIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2008-02-29
Application Number : 21992
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRISTIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2014-08-20
Application Number : 21992
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204028
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204028
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2023-12-07
Application Number : 204028
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2017-10-11
Application Number : 204020
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2017-10-11
Application Number : 204020
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2022-11-30
Application Number : 204020
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204095
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204095
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
